Obtenga las últimas noticias sobre las acciones de Quest Diagnostics con actualizaciones sobre las tendencias del mercado, las finanzas y el análisis de Benzinga. Manténgase informado sobre el rendimiento de DGX

Últimas noticias sobre

QUEST DIAGNOSTICS INC

Quest Diagnostics

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

News

Upgrades

Markets

Analyst Ratings

Trading Ideas

ASAN

LYFT

Conoce qué acciones recibieron mejoras clave de calificación por analistas de Wall Street y sus nuevos precios objetivo.

Analistas de Wall Street elevan precios objetivos y calificaciones de acciones clave

Quest Diagnostics Incorporated Common Stock

Quest Diagnostics Inc

Digi Power X Inc. - Common Subordinate Voting Shares

Digi Power X Inc

Press Releases

Quest Diagnostics to Offer FDA-Cleared Fujirebio Blood Test for Alzheimer's Disease

Quest Diagnostics Introduces Testing for Oropouche Virus

Earnings

Quest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025

Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing

Quest Diagnostics Completes Acquisition of Clinical Testing Assets from Fresenius Medical Care

Mass General Brigham Launches Two Clinical Trials to Study Haystack MRD ctDNA as Guide for Post-surgical Treatment for Two Cancer Types

Dividends

Quest Diagnostics Declares Quarterly Cash Dividend

Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference

FDA Grants Breakthrough Device Designation for Haystack MRD Circulating Tumor DNA Test from Quest Diagnostics

Corewell Health and Quest Diagnostics to Enter into Joint Venture Providing Enhanced Laboratory Services in Michigan

PACB

Addus HomeCare Corporation - Common Stock

Addus HomeCare

Astrana Health

Aveanna Healthcare Holdings Inc. - Common Stock

Aveanna Healthcare Hldgs

BrightSpring Health Services, Inc. - Common Stock

BrightSpring Health

Chemed

Cigna Group

CorVel

CVS Health

DaVita

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)

Fresenius Medical Care

Guardant Health

Hims & Hers Health, Inc. Class A Common Stock

Hims & Hers Health

Hinge Health

LifeStance Health Group, Inc. - Common Stock

LifeStance Health Gr

Labcorp Hldgs

Pediatrix Medical Group, Inc. Common Stock

Pediatrix Medical Group

Kindly MD

Omada Health

Option Care Health

OPKO Health

Premier

Pennant Gr

Privia Health Gr

RadNet

GeneDx Holdings Corp. - Class A Common Stock

GeneDx Holdings

Baird

Truist Securities

Deutsche Bank

JP Morgan

Screenshot 2025-04-15 at 7.03.21 PM

Biotech

MYNZ

Mainz Biomed Narrows Its Losses, Grows Revenue For Full Year 2024

Screenshot 2024-12-19 at 7.13.05 PM

General

Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S.

Comments

Quest Diagnostics Noticias bursátiles

Noticias

Últimas noticias sobre

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL